Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia, Acute Myelogenous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00809250
What this trial is testing

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome-Refractory Anemia With Excess Blasts
Dana-Farber Cancer Institute 33
Early research (Phase 1)Ended earlyNCT05607199
What this trial is testing

A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

Who this might be right for
Solid Tumor, AdultAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Aurigene Discovery Technologies Limited 27
Testing effectiveness (Phase 2)Study completedNCT00416598
What this trial is testing

Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia With Myelodysplasia-Related ChangesAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11+4 more
National Cancer Institute (NCI) 546
Not applicableStudy completedNCT02845232
What this trial is testing

Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly

Who this might be right for
Acute Myeloid Leukemia
Hospices Civils de Lyon 214
Testing effectiveness (Phase 2)Study completedNCT01170598
What this trial is testing

Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy

Who this might be right for
Acute Myeloid Leukemia
Toronto Rehabilitation Institute 35
Early research (Phase 1)Study completedNCT03197714
What this trial is testing

Clinical Trial of OPB-111077 in Patients With Relapsed or Refractory Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia
Hospital Universitario 12 de Octubre 9
Not applicableStudy completedNCT01608204
What this trial is testing

Busulfan Pharmacokinetic Analysis and GST Pharmacogenetic Profile in Adults Undergoing Hematological Stem Cell Transplantation

Who this might be right for
Acute Myeloid Leukemia
Rambam Health Care Campus 63
Early research (Phase 1)Looking for participantsNCT05263284
What this trial is testing

8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 30
Early research (Phase 1)Study completedNCT03393611
What this trial is testing

CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Relapsed Adult Acute Myeloid+1 more
Weill Medical College of Cornell University 14
Early research (Phase 1)Study completedNCT03787498
What this trial is testing

PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Who this might be right for
Relapsed Acute Myeloid Leukemia (AML)Refractory Acute Myeloid Leukemia (AML)High-risk Myelodysplastic Syndrome (MDS)
Opna Bio LLC 22
Not applicableStudy completedNCT04813263
What this trial is testing

Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants of Any Age With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
AbbVie 424
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06954987
What this trial is testing

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid Leukemia
National Cancer Institute (NCI) 244
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634536
What this trial is testing

Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaMyeloproliferative NeoplasmMyelodysplastic Syndromes
Stanford University 30
Large-scale testing (Phase 3)UnknownNCT01633099
What this trial is testing

Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients

Who this might be right for
Untreated Adult Acute Myeloid LeukemiaEffect of DrugsDrug Safety
Jianxiang Wang 46
Testing effectiveness (Phase 2)UnknownNCT01488344
What this trial is testing

Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
University Hospital Muenster 140
Early research (Phase 1)Ended earlyNCT02335814
What this trial is testing

First-in-Human Study of FLX925 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 51
Not applicableStudy completedNCT00365014
What this trial is testing

Progression of Hematopoietic Diseases in Shanghai, China

Who this might be right for
Hematologic Diseases
University of Colorado, Denver 10,757
Testing effectiveness (Phase 2)Study completedNCT01083706
What this trial is testing

Azacitidine in Treating Patients With Relapsed Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+9 more
Fred Hutchinson Cancer Center 43
Large-scale testing (Phase 3)Active Not RecruitingNCT04027309
What this trial is testing

Gilteritinib Versus Midostaurin in Combination With Induction and Consolidation Therapy Followed by One-year Maintenance in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndromes With Excess Blasts-2 With FLT3 Mutations Eligible for Intensive Chemotherapy

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland 777
Large-scale testing (Phase 3)UnknownNCT01484171
What this trial is testing

HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 50
Next Page